Science Explorer Back to mapMap
Discussion
Researcher · QED Technologies (United States) · United States

Gary Li

Gary Li publishes mostly in Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations and Phagocytosis and Immune Regulation.

ORCID 0000-0003-4090-7179 OpenAlex
World rank
#718,771
of 7,710,434 ranked researchers
Rank in United States
#242,358
of 1,627,098
Works
64
Citations
1.3k
Citations per work
20.0
h-index
15
i10-index 16Top 50% in Molecular Biology
Gary Li

What does Gary Li research?

Gary Li's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (8%).

Life Sciences: 23 works · 35.9% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 27.6% of their workMolecular Biology: 13 works · 20.0% of their workCancer Research: 5 works · 7.6% of their workImmunology and Microbiology: 5 works · 8.3% of their workImmunology: 5 works · 8.3% of their workHealth Sciences: 21 works · 33.1% of their workMedicine: 21 works · 33.1% of their workOncology: 8 works · 13.1% of their workRadiology, Nuclear Medicine and Imaging: 7 works · 11.0% of their workPulmonary and Respiratory Medicine: 6 works · 9.0% of their workEverything else: 20 works · 31.0% of their workTHEIR WORKGary Li64works
Life Sciences36%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1827.6%
    2. Immunology and Microbiology58.3%
    1. Medicine2133.1%
  3. Everything else2031.0%
  1. 1Molecular Biology20% of their works
  2. 2Oncology13% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Immunology8% of their works
  6. 6Cancer Research8% of their works

Research topics

Which keywords describe Gary Li's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, FGF21, Fibroblast Growth Factor, ALK Inhibitors, EGFR Mutations, apoptotic cells and CD47.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy244 topics
  2. Clinical Trials132 topics
  3. FGF2191 topic
  4. Fibroblast Growth Factor91 topic
  5. ALK Inhibitors81 topic
  6. EGFR Mutations81 topic
  7. CD4771 topic
  8. Fc Receptors71 topic
  9. PET Imaging71 topic
  10. Radiopharmaceuticals71 topic
  11. Therapeutic Antibodies71 topic
  12. apoptotic cells71 topic
  13. HIF-161 topic
  14. Warburg Effect61 topic
  15. Genomic Profiles51 topic
  16. Small-Cell Lung Cancer51 topic
  17. Cancer Genomics41 topic
  18. Mutational Signatures41 topic

Where does Gary Li work?

Gary Li's main affiliation in the publication record is QED Technologies (United States), United States.

How many publications and citations does Gary Li have?

OpenAlex counts 64 works and 1,277 citations for Gary Li, an h-index of 15, ranking #718,771 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gary Li. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.